ketanserin has been researched along with Apnea in 4 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Apnea: A transient absence of spontaneous respiration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To improve the pharmacological characterization of the receptors mediating 5-hydroxytryptamine (5-HT)-induced apnea the inhibitory effects of exogenous 5-HT on respiration and phrenic nerve activity (PNA) were studied in anesthetized rats." | 7.68 | Pharmacological characterization of 5-hydroxytryptamine-induced apnea in the rat. ( Goda, Y; Matsumoto, M; Saito, H; Togashi, H; Yoshioka, M, 1992) |
| " We show that repeated obstructive apneas disrupt vagal feedback and trigger LTF of hypoglossal motoneuron activity and genioglossus muscle tone." | 3.76 | Identification of a novel form of noradrenergic-dependent respiratory motor plasticity triggered by vagal feedback. ( Duffin, J; Peever, J; Tadjalli, A, 2010) |
| "kg(-1)) into the right femoral vein evoked prompt apnea, hypotension followed by tachypnoeic breathing." | 3.72 | 5HT2 and 5HT3 receptors' contribution to modeling of post-serotonin respiratory pattern in cats. ( Kopczyńska, B; Szereda-Przestaszewska, M, 2004) |
| "This study was aimed to prove the pharmacological characteristics of 5-hydroxytryptamine (5-HT)-induced respiratory depression, especially apnea." | 3.68 | [Ventilatory mechanical analysis of respiratory depression induced by serotonin]. ( Goda, Y, 1993) |
| "To improve the pharmacological characterization of the receptors mediating 5-hydroxytryptamine (5-HT)-induced apnea the inhibitory effects of exogenous 5-HT on respiration and phrenic nerve activity (PNA) were studied in anesthetized rats." | 3.68 | Pharmacological characterization of 5-hydroxytryptamine-induced apnea in the rat. ( Goda, Y; Matsumoto, M; Saito, H; Togashi, H; Yoshioka, M, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tadjalli, A | 1 |
| Duffin, J | 1 |
| Peever, J | 1 |
| Kopczyńska, B | 1 |
| Szereda-Przestaszewska, M | 1 |
| Goda, Y | 2 |
| Yoshioka, M | 1 |
| Togashi, H | 1 |
| Matsumoto, M | 1 |
| Saito, H | 1 |
4 other studies available for ketanserin and Apnea
| Article | Year |
|---|---|
Identification of a novel form of noradrenergic-dependent respiratory motor plasticity triggered by vagal feedback.
Topics: Adrenergic alpha-1 Receptor Antagonists; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; A | 2010 |
5HT2 and 5HT3 receptors' contribution to modeling of post-serotonin respiratory pattern in cats.
Topics: Animals; Apnea; Blood Pressure; Bradycardia; Cats; Dose-Response Relationship, Drug; Injections, Int | 2004 |
[Ventilatory mechanical analysis of respiratory depression induced by serotonin].
Topics: Airway Resistance; Animals; Apnea; Bronchoconstriction; Dose-Response Relationship, Drug; Ketanserin | 1993 |
Pharmacological characterization of 5-hydroxytryptamine-induced apnea in the rat.
Topics: Anesthesia; Animals; Apnea; Bronchoconstriction; Drug Interactions; Imidazoles; Ketanserin; Male; Me | 1992 |